| Name | Title | Contact Details |
|---|
HealthReveal is a clinical AI company dedicated to improving outcomes and quality of life for patients with chronic disease by enabling clinicians to deliver the most effective evidence-based treatments tailored to each patient’s unique circumstances, every time. By using machine learning and bridging each patient’s information with the latest medical guidelines, we predict individual patient health risks and disease progression and prescribe individual treatment interventions to mitigate risks, improve quality and reduce costs.
MedSym is a Tuscaloosa, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tru Grit set out to craft a line of professional grade fitness products for those who refuse to quit. Our passion for fitness and innovation inspires our team to create fitness equipment that are professional grade at an affordable price. Our products ...
Barry`s game-changing fitness classes offer our global community, the OG #FitFam, the Best Workout in the World® -- a workout that is as effective as it is fun. Founded in 1998, Barry`s has led the fitness industry in innovation. Today, you can experience our signature Red Room in more than 70 studios across 10 countries, as well as in the comfort of your own home. Whether you`re sprinting, lifting, or riding, in-studio or at-home, we`re on a mission to inspire you to work(out) hard, have fun, find your strength, and be your best.
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.